文献速递肿瘤 PET/CT核素与放射性配体治疗

基于18F-FDG PET/CT的影像组学联合剂量组学与剂量体积直方图对头颈癌的预后价值

Prognostic value of 18F-FDG PET/CT-based radiomics combining dosiomics and dose volume histogram for head and neck cancer.
PubMed 文献 · EJNMMI Res · 2023-02-13

本研究基于四个中心公共数据集的220例头颈癌病例,提取影像组学、剂量组学和剂量体积直方图特征,构建七种PET、CT及剂量特征组合模型预测总生存。PET+CT+Dose模型在三组验证集中C-index分别为0.873、0.759和0.835,整体优于其余模型,并在三组实验中均能区分高、低风险组(p<0.05)。

要点

  • 基于18F-FDG PET/CT的影像组学联合剂量组学与DVH特征构建多维模型预测头颈癌总生存。
  • PET+CT+Dose模型在三组验证集中C-index分别为0.873、0.759和0.835,整体优于其余模型。
  • PET+CT+Dose模型在三组实验中均能区分高、低风险组(p<0.05)。

核心结论

  • 联合剂量组学特征和DVH特征的影像组学多维模型对预测头颈癌患者总生存表现出较高的预后性能。

研究设计与样本

  • 本研究使用癌症影像档案公共数据集中来自四个中心的220例病例。
  • 每例提取2260个影像组学特征、1116个剂量组学特征和8个DVH特征,分为PET、CT、Dose、PET+CT、PET+Dose、CT+Dose和PET+CT+Dose七种模型。
  • 特征经单因素Cox和Spearman相关系数筛选后纳入LASSO-Cox模型,并构建列线图进行可视化分析。
  • 采用C-index和Kaplan-Meier曲线(log-rank分析)评估和比较各模型。
  • 四个中心的病例按医院分为三组不同的训练集和验证集。

主要发现

  • PET+CT+Dose模型在三组验证集中的C-index分别为0.873(95%CI 0.812-0.934)、0.759(95%CI 0.663-0.855)和0.835(95%CI 0.745-0.925),整体优于其余模型。
  • PET+CT+Dose模型在三组不同实验中均能区分高、低风险组(p<0.05)。

关键数值与推荐

  • PET+CT+Dose模型在三组验证集中的C-index分别为0.873(95%CI 0.812-0.934)、0.759(95%CI 0.663-0.855)和0.835(95%CI 0.745-0.925)。
  • PET+CT+Dose模型在三组实验中区分高、低风险组的p值均<0.05。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: By comparing the prognostic performance of 18F-FDG PET/CT-based radiomics combining dose features [Includes Dosiomics feature and the dose volume histogram (DVH) features] with that of conventional radiomics in head and neck cancer (HNC), multidimensional prognostic models were constructed to investigate the overall survival (OS) in HNC. MATERIALS AND METHODS: A total of 220 cases from four centres based on the Cancer Imaging Archive public dataset were used in this study, 2260 radiomics features and 1116 dosiomics features and 8 DVH features were extracted for each case, and classified into seven different models of PET, CT, Dose, PET+CT, PET+Dose, CT+Dose and PET+CT+Dose. Features were selected by univariate Cox and Spearman correlation coefficients, and the selected features were brought into the least absolute shrinkage and selection operator (LASSO)-Cox model. A nomogram was constructed to visually analyse the prognostic impact of the incorporated dose features. C-index and Kaplan-Meier curves (log-rank analysis) were used to evaluate and compare these models. RESULTS: The cases from the four centres were divided into three different training and validation sets according to the hospitals. The PET+CT+Dose model had C-indexes of 0.873 (95% CI 0.812-0.934), 0.759 (95% CI 0.663-0.855) and 0.835 (95% CI 0.745-0.925) in the validation set respectively, outperforming the rest models overall. The PET+CT+Dose model did well in classifying patients into high- and low-risk groups under all three different sets of experiments (p < 0.05). CONCLUSION: Multidimensional model of radiomics features combining dosiomics features and DVH features showed high prognostic performance for predicting OS in patients with HNC.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Wang B, Liu J, Zhang X, et al. Prognostic value of 18F-FDG PET/CT-based radiomics combining dosiomics and dose volume histogram for head and neck cancer. EJNMMI Res. 2023. PMID: 36779997. doi:10.1186/s13550-023-00959-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。